Tokyo, Japan

Miyuki Sakai

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fronteo, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miyuki Sakai. Retrieved from https://idiyas.com/inventor/miyuki-sakai-erlt774t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miyuki Sakai and Her Patent in Disease Pathway Analysis

Introduction

Miyuki Sakai is an inventor associated with Fronteo, Inc. in Tokyo, Japan. Her patent work includes an apparatus, method, and program for analyzing disease pathways and identifying shared and distinct portions of those pathways.

Latest Patents

The provided information lists one patent for Miyuki Sakai: “Pathway Analysis Apparatus, Pathway Analysis Method, and Pathway Analysis Program.” The invention detects a partial common path between the start and end points of pathways representing molecular interactions associated with different diseases. It also presents the shared path and the non-shared paths, or their constituent molecules, in a way that makes their differences distinguishable. This approach can help users understand how a disease pathway changes when a disease’s state changes. Sakai is credited with 1 patent in the information provided.

Career Highlights

Sakai’s listed invention focuses on organizing and comparing disease pathway information. By distinguishing common sections from sections that differ, the technology is designed to make changes in molecular interactions easier to interpret.

Collaborations

The provided information associates Sakai with Fronteo, Inc. and names Kazumi Hayashi and Hiroyoshi Toyoshiba as coworkers. It does not specify their roles in the patent or describe the nature of their collaboration.

Conclusion

Miyuki Sakai’s listed patent addresses the comparison of disease pathways by clearly identifying shared and distinct segments, offering a structured way to examine pathway changes associated with disease-state transitions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…